Characteristics of the nine studies that examined the association between genome-wide gene expression profiles measured in breast cancer tissues and response to HER2-targeted therapies in HER2-positive breast cancer patients are presented in Supplementary Table 4. Here, ERBB2 is linked to breast carcinoma.